Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity : possible implications for opiate addiction

作者: Cherie Bond , K. Steven LaForge , Mingting Tian , Dorothy Melia , Shengwen Zhang

DOI: 10.1073/PNAS.95.16.9608

关键词:

摘要: Opioid drugs play important roles in the clinical management of pain, as well development and treatment drug abuse. The mu opioid receptor is primary site action for most commonly used opioids, including morphine, heroin, fentanyl, methadone. By sequencing DNA from 113 former heroin addicts methadone maintenance 39 individuals with no history or alcohol abuse dependence, we have identified five different single-nucleotide polymorphisms (SNPs) coding region gene. prevalent SNP a nucleotide substitution at position 118 (A118G), predicting an amino acid change putative N-glycosylation site. This displays allelic frequency approximately 10% our study population. Significant differences allele distribution were observed among ethnic groups studied. variant resulting A118G did not show altered binding affinities peptides alkaloids tested. However, binds β-endorphin, endogenous that activates receptor, three times more tightly than common form receptor. Furthermore, β-endorphin potent agonist-induced activation G protein-coupled potassium channels. These results SNPs gene can alter signal transduction may implications normal physiology, therapeutics, vulnerability to develop protection diverse diseases addictive diseases.

参考文章(42)
Charles Chavkin, Electrophysiology of Opiates and Opioid Peptides Humana Press, Totowa, NJ. pp. 273- 303 ,(1988) , 10.1007/978-1-60761-990-1_9
M.J. Kreek, S.L. Wardlaw, J. Friedman, B. Schneider, A.G. Frantz, EFFECTS OF CHRONIC EXOGENOUS OPIOID ADMINISTRATION ON LEVELS OF ONE ENDOGENOUS OPIOID (β-ENDORPHIN) IN MAN Advances in Endogenous and Exogenous Opioids#R##N#Proceedings of the International Narcotic Research Conference (Satellite Symposium of the 8th International Congress of Pharmacology) Held in Kyoto, Japan on July 26–30, 1981. pp. 364- 366 ,(1981) , 10.1016/B978-0-444-80402-0.50123-6
Kreek Mj, Opiates, opioids and addiction. Molecular Psychiatry. ,vol. 1, pp. 232- 254 ,(1996)
W. Rosenthal, A. Antaramian, S. Gilbert, M. Birnbaumer, Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase. Journal of Biological Chemistry. ,vol. 268, pp. 13030- 13033 ,(1993) , 10.1016/S0021-9258(19)38614-4
J F Parkinson, B W Grinnell, R E Moore, J Hoskins, C J Vlahos, N U Bang, Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. Journal of Biological Chemistry. ,vol. 265, pp. 12602- 12610 ,(1990) , 10.1016/S0021-9258(19)38386-3
Jia-Bei Wang, Peter S. Johnson, Antonio M. Persico, Anita L. Hawkins, Constance A. Griffin, George R. Uhl, Human μ opiate receptor: cDNA and genomic clones, pharmacologic characterization and chromosomal assignment FEBS Letters. ,vol. 338, pp. 217- 222 ,(1994) , 10.1016/0014-5793(94)80368-4
G. Hayes, A. Busch, M. Lötscher, S. Waldegger, F. Lang, F. Verrey, J. Biber, H. Murer, Role of N-linked glycosylation in rat renal Na/Pi-cotransport. Journal of Biological Chemistry. ,vol. 269, pp. 24143- 24149 ,(1994) , 10.1016/S0021-9258(19)51060-2
B.W. Grinnell, J.D. Walls, B. Gerlitz, Glycosylation of human protein C affects its secretion, processing, functional activities, and activation by thrombin Journal of Biological Chemistry. ,vol. 266, pp. 9778- 9785 ,(1991) , 10.1016/S0021-9258(18)92888-7